Vaccination News Home Page subscribe Vaccination NewsLetter
http://www.hum-molgen.de/NewsGen/03-2003/msg06.html
| Autopsy Exposes Adverse Effects Of Alzheimer's Vaccine | ||||||
| March, 17 2003 9:46 |
|
|||||
| The only clinical trial
for an experimental Alzheimer disease (AD) vaccine was halted last
year when 15 of the trial participants developed severe brain
inflammation. In the April issue of
Nature Medicine,
James Nicoll and colleagues present the first analysis of the
vaccine's effects on the human brain.
In the US alone, AD affects nearly 4 million people, and the number is expected to triple in the next 30 years. The brain of an AD patient is characterized by tangled bundles of nerve fibers and amyloid 'plaques' -- clusters of a sticky protein called amyloid-beta. In mice, a vaccine directed against the amyloid-beta peptide clears the plaques and alleviates the memory loss associated with AD. Scientists had hoped it would do the same in people. The autopsy of a patient from the halted trial reveals that in people, too, the vaccine clears the amyloid-beta peptide from most areas of the brain. The researchers also report evidence of meningoencephailitis, which is not characteristic of AD patients' brains, and suggest that it is a direct consequence of the vaccine. The results do not dismiss the potential usefulness of a vaccine for AD, they say, but should guide future experiments. Author contact: James A.R. Nicoll Tel: +44 2380 796634 Author of accompanying News & Views piece: Bradley T. Hyman Tel: +1 617 726 2299 Also available online.
|
||||||
|
Generated by News Editor 2.0 by Kai Garlipp |
||||||
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.